[ad_1]
The maker of the widespread weight reduction drug Wegovy stated Wednesday that it's ramping up manufacturing of the drug, which has been in brief provide in pharmacies throughout the USA.
The drug confronted widespread shortages final yr as a consequence of its rising recognition, executives for drugmaker Novo Nordisk, stated on a name with traders Wednesday.
“We all know for a proven fact that sufferers have been lined up,” firm CEO Lars Jorgensen stated on the decision.
Novo Nordisk stated on Dec. 28 that each one dosages of the drug can be out there once more after provide points, however added that it might take time for the drug to reach at pharmacies from distribution facilities.
There continues to be “pent up demand” for Wegovy, however Novo Nordisk expects this to grow to be much less of an issue as extra provide of the drug turns into out there over the subsequent few months, Jorgensen stated.
“We're clearly inspired by the trendline we see, however we additionally do imagine there will likely be a normalization of that," he stated.
Wegovy, or semaglutide, is a part of a category of medication referred to as GLP-1 agonists. They mimic a hormone that helps scale back meals consumption and lower urge for food. In medical trials, Wegovy was proven to scale back physique weight by round 15%.
The drug is pricy, costing round $1,300 a month, and insurance coverage firms typically do not cowl it.
Shortages of Wegovy have compelled some folks within the U.S. to cease taking it, main them to achieve some — or all — of their weight again.
Others have been prescribed Ozempic off-label for weight reduction, inflicting shortages of that drug. Ozempic is identical remedy as Wegovy, simply in a decrease dose, and is accepted to be used in folks with Sort 2 diabetes to manage their blood sugar ranges. Each are made by Novo Nordisk.
Doug Langa, head of North American operations at Novo Nordisk, famous on the decision the difficulties that sufferers have had discovering the remedy, however added that the corporate now "appears ahead" to the drug being extra extensively out there.
Observe NBC HEALTH on Twitter & Fb.
[ad_2]
Supply hyperlink https://classifiedsmarketing.com/?p=33617&feed_id=123634